BIOLOGICAL THERAPY IN ADULT PATIENTS WITH ULCERATIVE COLITIS AND CROHN'S DISEASE: BUDGET IMPACT ANALYSIS

• প্রধান লেখক: E. A. Pyadushkina (লেখক)
• বিন্যাস: গ্রন্থ
• প্রকাশিত: IRBIS LLC, 2017-05-01T00:00:00Z.
• বিষয়গুলি: article
• অনলাইন ব্যবহার করুন: Connect to this object online.

Aims of the study: to assess health care costs of the use of biological agents (vedolizumab and various TNF-α inhibitors) in adult patients with moderate to severe active ulcerative colitis (UC) and moderate or severe active Crohn's disease (CT) with an unsatisfactory response, loss of response...